BioAlliance Pharma makes appointment
Judith Greciet put in charge of operations and r&d as deputy chief operating officer
Greciet joins the company from Eisai France, a company she managed as president for three years. Eisai France, with a €120m turnover, is focused on the Alzheimer’s disease field.
Greciet started at Eisai France in June 2007 after working for Wyeth Pharmaceuticals France (today Pfizer), French biopharmaceutical firm LFB Group, Zeneca and Pharmacia, where she held operational and strategic positions.